Autophagy in Prostate Cancer and Androgen Suppression Therapy
Open Access
- 5 June 2013
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (6), 12090-12106
- https://doi.org/10.3390/ijms140612090
Abstract
The role of autophagy is known to be highly complex and context-dependent, leading to both cancer suppression and progression in several tumors including melanoma, breast and prostate cancer. In the present review, recent advances in an understanding of the involvement of autophagy in prostate cancer treatment are described. The regulatory effects of androgens on prostate cancer cell autophagy are particularly discussed in order to highlight the effects of autophagy modulation during androgen deprivation. A critical evaluation of the studies examined in the present review suggests the attractive possibility of autophagy inhibition combined with hormonal therapy as a promising approach for prostate cancer treatment.This publication has 78 references indexed in Scilit:
- AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxiaCellular Signalling, 2011
- Principles and Current Strategies for Targeting Autophagy for Cancer TreatmentClinical Cancer Research, 2011
- Targeting Tyrosine Kinases and Autophagy in Prostate CancerHormones and Cancer, 2010
- Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitmentProceedings of the National Academy of Sciences of the United States of America, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagyThe EMBO Journal, 2010
- Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cellsOncogene, 2009
- Apoptosis and autophagy: Targeting autophagy signalling in cancer cells –‘trick or treats’?The FEBS Journal, 2009
- A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasiaProceedings of the National Academy of Sciences of the United States of America, 2009
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005